Anteilseigner
Viking Global Investors LP (8,53 %) RA Capital Management LP (8,36 %) Venrock Associates (6,88 %) Janus Henderson Investors US LLC (6,18 %) BlackRock Fund Advisors (5,89 %) Deep Track Capital LP (4,59 %) The Vanguard Group, Inc. (3,65 %) SSgA Funds Management, Inc. (3,06 %) Novo Holdings A/ S (Investment Company) (3,01 %) Morgan Stanley & Co. LLC (2,98 %) ArrowMark Colorado Holdings LLC (2,41 %) Casdin Capital LLC (2,08 %) Geode Capital Management LLC (1,56 %) Goldman Sachs & Co. LLC (Private Banking) (1,49 %) Dimensional Fund Advisors LP (1,40 %) Deerfield Management Co. LP (Private Equity) (1,31 %) Eagle Health Investments LP (0,88 %) Assenagon Asset Management SA (Germany) (0,86 %)
Kontakt
4D Molecular Therapeutics Inc.